Clinical Trials Browser

Phase 2 × Erythroplasia × 90 days × Clear all

NCT02581137 2026-03-18

Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

Phase 2 Active not recruiting

26 enrolled 10 charts

Erythroplasia, Hyperplasia, Leukoplakia, Oral, Mouth Neoplasms